BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 31193998)

  • 1. Remote monitoring: Doomed to let down or an attractive promise?
    Lucà F; Cipolletta L; Di Fusco SA; Iorio A; Pozzi A; Rao CM; Ingianni N; Benvenuto M; Madeo A; Fiscella D; Benedetto D; Francese GM; Gelsomino S; Zecchin M; Gabrielli D; Gulizia MM
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100380. PubMed ID: 31193998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.
    Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F
    Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
    Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
    Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lockdown during COVID-19 pandemic on physical activity and arrhythmia burden in heart failure patients.
    Schmitt J; Wenzel B; Brüsehaber B; Anguera I; de Sousa J; Nölker G; Bulava A; Marques P; Hatala R; Golovchiner G; Meyhöfer J; Ilan M;
    Pacing Clin Electrophysiol; 2022 Apr; 45(4):471-480. PubMed ID: 34997979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(7):1-199. PubMed ID: 30443279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
    Braunschweig F; Anker SD; Proff J; Varma N
    Europace; 2019 Jun; 21(6):846-855. PubMed ID: 30903152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices.
    Lüthje L; Vollmann D; Seegers J; Sohns C; Hasenfuß G; Zabel M
    Europace; 2015 Aug; 17(8):1276-81. PubMed ID: 25983310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational model and reactions to alerts in remote monitoring of cardiac implantable electronic devices: A survey from the Home Monitoring Expert Alliance project.
    Zanotto G; D'Onofrio A; Della Bella P; Solimene F; Pisanò EC; Iacopino S; Dondina C; Giacopelli D; Gargaro A; Ricci RP
    Clin Cardiol; 2019 Jan; 42(1):76-83. PubMed ID: 30421438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.
    Varma N
    Am Heart J; 2007 Dec; 154(6):1029-34. PubMed ID: 18035071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote monitoring of cardiac implantable electronic devices (CIED).
    Zeitler EP; Piccini JP
    Trends Cardiovasc Med; 2016 Aug; 26(6):568-77. PubMed ID: 27134007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of remote monitoring after implantable defibrillators implantation in heart failure patients: an analysis from the EFFECT study.
    Capucci A; De Simone A; Luzi M; Calvi V; Stabile G; D'Onofrio A; Maffei S; Leoni L; Morani G; Sangiuolo R; Amellone C; Checchinato C; Ammendola E; Buja G
    Europace; 2017 Sep; 19(9):1493-1499. PubMed ID: 28407139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
    Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
    Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote Monitoring for Follow-up of Patients with Cardiac Implantable Electronic Devices.
    Ricci RP; Morichelli L; Varma N
    Arrhythm Electrophysiol Rev; 2014 Aug; 3(2):123-8. PubMed ID: 26835079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients' apps combined with remote monitoring?
    Sgreccia D; Mauro E; Vitolo M; Manicardi M; Valenti AC; Imberti JF; Ziacchi M; Boriani G
    Expert Rev Med Devices; 2022 Feb; 19(2):155-160. PubMed ID: 35129023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
    Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
    Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society.
    Varma N; Cygankiewicz I; Turakhia MP; Heidbuchel H; Hu Y; Chen LY; Couderc JP; Cronin EM; Estep JD; Grieten L; Lane DA; Mehra R; Page A; Passman R; Piccini JP; Piotrowicz E; Piotrowicz R; Platonov PG; Ribeiro AL; Rich RE; Russo AM; Slotwiner D; Steinberg JS; Svennberg E
    Cardiovasc Digit Health J; 2021 Feb; 2(1):4-54. PubMed ID: 35265889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors.
    Abraham WT
    Europace; 2013 Jun; 15 Suppl 1():i40-i46. PubMed ID: 23737229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
    Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
    Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.